Skip to main content
Clinical Trials/NCT04105647
NCT04105647
Unknown
Not Applicable

A Brief Messaging Lifestyle Modification Program for Patients With Non-small Cell Lung Cancer - A Pilot Study

The University of Hong Kong2 sites in 1 country32 target enrollmentOctober 1, 2019
ConditionsCancer, Lung

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer, Lung
Sponsor
The University of Hong Kong
Enrollment
32
Locations
2
Primary Endpoint
Change in fatigue level at 6 weeks
Last Updated
6 years ago

Overview

Brief Summary

Lung cancer is one of the most common cancer diseases, globally and locally. Several health benefits of increased physical activity (PA) have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality.

Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Hence, the investigators propose to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise into daily activities of patients with lung cancer. The aims are to increase patients' physical activity and improve their fatigue, emotion and quality of life, compared to the control group.

Detailed Description

Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer are in a uniquely challenging situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning. Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to post-diagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Low motivation, fear to exercise, lack of knowledge about benefits are the most common barriers of engaging in physical activity for cancer patients. Hence, the current proposal is to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise (light to moderate physical activity) into daily activities of patients with lung cancer. The investigators hypothesised that patients in the experimental group would display significantly higher increases in physical activity and improvements in fatigue, emotion and quality of life, compared to the control group. The objectives are to examine the short-term clinical effects on impacts on fatigue, emotion and quality of life in patients with lung cancer, and to evaluate the feasibility of a brief lifestyle-integrated exercise program to increase physical activity by a pilot study with objective fitness and subjective questionnaire assessment, and focus group interviews.

Registry
clinicaltrials.gov
Start Date
October 1, 2019
End Date
May 30, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Agnes Yuen-Kwan Lai

Assistant Professor

The University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years and above;
  • Diagnosis with non-small cell lung cancer
  • General condition stable, either is undergoing or finished treatment
  • Able to speak and read Chinese
  • Able to complete the self-administered questionnaire
  • Able to use instant messages such as WhatsApp or WeChat
  • Mental, cognitive and physically fit determined by the clinicians/investigators
  • Signed informed consent

Exclusion Criteria

  • Pre-operative lung cancer
  • Skeletal fragility
  • Serious active infection
  • Inability to walk
  • Previously untreated symptomatic brain metastases
  • Severe respiratory insufficiency
  • Uncontrolled pain

Outcomes

Primary Outcomes

Change in fatigue level at 6 weeks

Time Frame: Baseline and 6 weeks

measured by Brief Fatigue Inventory

Secondary Outcomes

  • Change in activity level at 6 weeks(Baseline and 6 weeks)
  • Change in health-related quality of life at 6 weeks(Baseline and 6 weeks)
  • Change in excessive daytime sleepiness at 6 weeks(Baseline and 6 weeks)
  • Change in physical activity at 6 weeks(Baseline and 6 weeks)
  • Change in insomnia level at 6 weeks(Baseline and 6 weeks)
  • Change in balance at 6 weeks(Baseline and 6 weeks)
  • Change in flexibility at 6 weeks(Baseline and 6 weeks)
  • Change in endurance at 6 weeks(Baseline and 6 weeks)
  • Change in functional level at 6 weeks(Baseline and 6 weeks)
  • Change in anxiety and depression symptoms at 6 weeks(Baseline and 6 weeks)
  • Change in sleep quality at 6 weeks(Baseline and 6 weeks)
  • Change in hand grips strength at 6 weeks(Baseline and 6 weeks)
  • Change in lower limb strength at 6 weeks(Baseline and 6 weeks)

Study Sites (2)

Loading locations...

Similar Trials